{"cluster": 48, "subcluster": 36, "abstract_summ": "We extracted data from eligible studies to summarize the clinical manifestations and laboratory indexes of kidney injury on COVID-19 infection patients and further compared the prevalence of acute kidney injury (AKI) and the mean differences of three biomarkers between in ICU/severe and non-ICU/non-severe cases.The proportion of underlying diseases such as hypertension, diabetes, cardiovascular disease, and respiratory disease were statistically significant higher in critical/mortal patients compared to the non-critical patients (diabetes: OR=3.68, 95% CI (2.68, 5.03), P < 0.00001; hypertension: OR = 2.72, 95% CI (1.60,4.64), P = 0.0002; cardiovascular disease: OR = 5.19, 95% CI(3.25, 8.29), P < 0.00001; respiratory disease: OR = 5.15, 95% CI(2.51, 10.57), P < 0.00001).RESULTS: A total of 24 studies involving 4963 confirmed COVID-19 patients were included.On average, ARDS occurred in 14% of patients (95% PI, 2 to 59%; 999/6322 patients; 23 studies), acute cardiac injury in 15% (95% PI, 5 to 38%; 452/2389 patients; 10 studies), venous thromboembolism in 15% (95% PI, 0 to 100%; patients; 3 studies), acute kidney injury in 6% (95% PI, 1 to 41%; 318/4682 patients; 15 studies), coagulopathy in 6% (95% PI, 1 to 39%; 223/3370 patients; 9 studies), and shock in 3% (95% PI, 0 to 61%; 203/4309 patients; 13 studies).METHODS: We searched PubMed and Embase for studies that evaluated cardiac injury in hospitalized COVID-19 patients.", "title_summ": "The Chronic Kidney Disease and Acute Kidney Injury Involvement in COVID-19 Pandemic: A Systematic Review and Meta-analysisIncidence and risk factors of kidney impairment on patients with COVID-19: a systematic review and meta-analysisCardiac Injury and COVID-19: A Systematic Review and Meta-AnalysisDoes comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisThe impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysisCoronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious eventsPrognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-AnalysisRisk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisAcute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysisPrevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysisMultiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-AnalysisCardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.", "title_abstract_phrases": "The proportion of underlying diseases such as hypertension, diabetes, cardiovascular disease, and respiratory disease were statistically significant higher in critical/mortal patients compared to the non-critical patients (diabetes: OR=3.68, 95% CI (2.68, 5.03), P < 0.00001; hypertension: OR = 2.72, 95% CI (1.60,4.64), P = 0.0002; cardiovascular disease: OR = 5.19, 95% CI(3.25, 8.29), P < 0.00001; respiratory disease: OR = 5.15, 95% CI(2.51, 10.57), P < 0.00001).RESULTS: A total of 24 studies involving 4963 confirmed COVID-19 patients were included.We extracted data from eligible studies to summarize the clinical manifestations and laboratory indexes of kidney injury on COVID-19 infection patients and further compared the prevalence of acute kidney injury (AKI) and the mean differences of three biomarkers between in ICU/severe and non-ICU/non-severe cases.CONCLUSION: Male, aged over 65, smoking patients might face a greater risk of developing into the critical or mortal condition and the comorbidities such as hypertension, diabetes, cardiovascular disease, and respiratory diseases could also greatly affect the prognosis of the COVID-19.Results We included 4189 confirmed COVID-19 infected patients from 28 studies."}